Intensive Monitoring in Portugal: a Model to Assess Medicines in Real-Life Conditions. Antidiabetics as example. (MOMI)

First published 25/01/2015

Last updated 02/04/2024

EU PAS number:

EUPAS8433

Study

Ongoing

Download as PDF

Documents

Study protocol

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Conflicts of interest of investigators

Declaração de Honra

English (132.63 KB - PDF)View document

Intensive Monitoring in Portugal: a Model to Assess Medicines in Real-Life Conditions. Antidiabetics as example. (MOMI)

Secondary tabs

Share this page